1 / 49

Medication Safety Review HKEH QA Forum 2012

Medication Safety Review HKEH QA Forum 2012. Presented by David CHOI Resident Pharmacist, HKEH 22/March 2012. MI Reported to Drug Monitoring Committee in 2011. Entry of Complicated Regimen.

verlee
Télécharger la présentation

Medication Safety Review HKEH QA Forum 2012

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Medication Safety Review HKEH QA Forum 2012 Presented by David CHOI Resident Pharmacist, HKEH 22/March 2012

  2. MI Reported to Drug Monitoring Committee in 2011

  3. Entry of Complicated Regimen The system allows entry of 5 different regimen types. Doctors no longer need to enter the dosage instruction in the special instruction box for majority of the case.

  4. Entry of Complicated Regimen Example of tapering dose regimen

  5. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( I ) • HA approved abbreviations • "Vitamin" abbreviated to Vit e.g. Vit B12, Vit E • Chemical name acronym • Abbreviation well established in medical literature • Low risk of misinterpretation with other abbreviations / drug names • Common knowledge of abbreviation by all health care professionals within organisation (HA)

  6. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( II )

  7. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( III )

  8. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( IV )

  9. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( V )

  10. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( VI )

  11. List of KCC Approved / Standard Drug Abbreviations in Prescribing Approved and adopted by Medication Safety Committee KCC,(Last updated Aug 2010) ( VII )

  12. Common Abbreviations being used in HKEH Dexamethasone 0.1% + Chloramphenicol 0.5% 5ml Optomycin-D Decadron-C  DC  Dexamethasone 0.1% + Neomycin 0.5% 10ml Dexoptic-N  Decadron-N  DN  Mydrin-P Eye Drops 10ml Mydrin-P  MP 

  13. G6PD Deficiency Contraindication Checking The local G6PD deficiency contraindicated drug lists used at HA hospitals were found to be quite inconsistent as users consult different reference sources when they prepare the list. The computerized G6PD deficiency contraindication checking is sourced from clinical data provided by First Data Bank, Inc. (FDB). You might notice discrepancies between FDB’s G6PD deficiency contraindicated drug list and the one prepared by local hospital. Through rounds of discussion, doctors in Medication Order and Decision Support Working Group (MODSWG), CPO and FDB representatives collaborated to review and fine-tune FDB’s list to be used for this G6PD deficiency contraindication checking. All quinolones except Nalidixic Acid are not included in the FDB’s G6PD deficiency contraindicated drug list because FDB has contacted Dr. Ernest Beutler, MD of Scripps Research Institute and leading expert on G6PD deficiencyand Dr. Beutler replied that he was not aware of any documented case reports of quinolones causing hemolysis in G6PD deficient individuals.

  14. Case • Allergen: Amiodarone HCL • Pregnancy Contraindication Checking: ON • Current Rx: • Amiodarone HCL Tablet • Sotalol HCL Tablet • On Hand Drug: • Propafenone HCL Tablet

  15. Case (with on hand drug Propafenone)

  16. Case (with on hand drug Propafenone)

  17. Perform patient-specific clinical checking (including drug allergy checking, G6PD deficiency and pregnancy contraindicated checking) upon clicking “Edit” or “Add” button on the drug search screen Case (with on hand drug Propafenone)

  18. Case (with on hand drug Propafenone)

  19. Case (with on hand drug Propafenone)

  20. Case (with on hand drug Propafenone)

  21. Case (with on hand drug Propafenone)

  22. Perform drug-drug interaction checking upon clicking “Save and Print” button Case (with on hand drug Propafenone)

  23. Check Amiodarone against other drug(s) on the current Rx. Case (with on hand drug Propafenone)

  24. Check Amiodarone against local on-hand drug Case (with on hand drug Propafenone)

  25. Case (with on hand drug Propafenone)

  26. Case (with on hand drug Propafenone)

  27. HA list of High Risk Medications

  28. LASA (Look-Alike Sound-Alike) Medications (I)

  29. LASA (Look-Alike Sound-Alike) Medications (II)

  30. LASA (Look-Alike Sound-Alike) Medications (III)

  31. LASA (Look-Alike Sound-Alike) Medications (IV)

  32. LASA (Look-Alike Sound-Alike) Medications (V) QEH LASA Drug List : DuoTRAV / DuraTEARS TRAMadol / PANAdol XalaCOM / XalaTAN HKE LASA Drug List : XalaCOM / XalaTAN 1% Pilocarpine / 2% Pilocarpine / 4% Pilocarpine Maxitrol Oc. / Maxidex Oc.

  33. Acknowledgement Presentation materials Prepared by Mr Ng Chi Ming HKE DM(Pharm)

  34. Thank You

More Related